期刊文献+

骨髓NKT细胞活性与儿童再生障碍性贫血相关性研究 被引量:2

Bone marrow natural killer T cell activity in children with aplastic anemia
下载PDF
导出
摘要 目的探讨骨髓中自然杀伤T细胞(nature killer T cell,NKT)在再生障碍性贫血免疫介导发病机制中的作用。方法选取14例确诊儿童再生障碍性贫血为再生障碍性贫血组,同年龄正常儿童10例为对照组。流式细胞术检测两组儿童骨髓中NKT含量;利用免疫磁珠法分离纯化NKT细胞后,分别在4种不同体系下进行扩增培养。A:α-Galcer+rhIL-2;B:α-Galcer+rhIL-2+rhG-CSF;C:OCH+rhIL-2;D:OCH+rhIL-2+rhG-CSF。测定NKT细胞在不同培养条件下的扩增倍数;利用酶联免疫斑点技术(Elispot)测定NKT细胞扩增活化后表达IFN-γ、IL-4的斑点形成细胞数(SFCs)。结果再生障碍性贫血组骨髓中NKT百分率(0.827%±0.022%)明显低于对照组(1.033%±0.073%,Z=-3.810,P=0.000)。在各培养体系中,再生障碍性贫血组和对照组骨髓NKT均可明显扩增。在含有α-Galcer培养体系A和B中,再生障碍性贫血组及对照组NKT细胞的扩增能力均高于OCH体系C和D,差异有统计学意义(P<0.01或P<0.05)。在培养体系中加入rhG-CSF后,再生障碍性贫血组骨髓NKT细胞的扩增能力下降(P<0.01),但表达IFN-γ的SFCs明显减少(P均<0.01);而表达IL-4的SFCs明显升高(P均<0.01)。结论再生障碍性贫血患儿骨髓NKT的数量和功能均明显低于正常儿童。但再生障碍性贫血骨髓在接受细胞配体(OCH或α-Galcer)+rhIL-2+rhG-CSF作用后,在获得NKT细胞一定程度扩增的同时,提高NKT的IL-4表达,降低NKT的IFN-γ表达,抑制T细胞向Th1分化,而促进T细胞向Th2分化,逆转再生障碍性贫血Th1/Th2异常失衡的免疫介导致病机制,可能成为获得性再生障碍性贫血的有效治疗途径。 Objective To investigate activity of bone marrow nature killer T cell (NKT) and its relation to pathogenesis of aplastic anemia(AA) in children. Methods Fourteen children with aplastic anemia were included in the study and 10 healthy children were selected as controls. The proportion of NKT cells in bone marrow was measured by flow cytometry. Immune magnetic bead separation was used to isolate and purify NKT cells. The purified NKT cells were cultured in four different culture systems. A: α-Galcer and rhlL-2 ; B : α-Galcer, rhIL-2 and rhG-CSF ;C : OCH and rhlL-2 ; D : OCH, rhlL-2 and rhG-CSF. The amplification of NKT cells after cultured in different systems was calculated. Elispot method was used to analyze the sporing form cells (SFCs) expressing IFN-γ or IL-4. Results The percentage of NKT cells in bone marrow of AA group ( 0. 872%± 0. 022% ) was significantly lower than control group ( 1. 033 % ± 0. 073 %, Z = - 3.810, P = 0. 000 ). In each culture system, the bone marrow NKT cells in both groups were significantly amplified. In system A and B containing α-Galeer, the proliferation ability of NKT ceils from both AA group and control group were higher than that in C and D ( OCH system) ( P 〈 0.01 or P 〈 0.05 ). rhG-CSF decreased the expansion of NKT cells but resulted in decreased SFCs of IFN-γ and elevated SFCs of IL-4 in AA group(P 〈0.01 ). Conclusion The quantity and function of NKT cells from children with aplastic anemia are lower than those from healthy children. But NKT cells can be amplified and its function can be improved by interaction with cell ligand OCH or α-Galcer, rhIL-2 and rhG-CSF, which might be a potential therapeutic approach for AA.
出处 《同济大学学报(医学版)》 CAS 2016年第2期35-39,73,共6页 Journal of Tongji University(Medical Science)
基金 上海市科委重点项目(11JC1411900) 上海市卫生局重大项目(2010002)
关键词 再生障碍性贫血 自然杀伤T细胞 α-半乳糖神经酰胺 OCH aplastic anemia natural Miler T cells α-galactosylceramide OCH
  • 相关文献

参考文献12

  • 1Marsh JCW, Ball SE, Cavenagh J, et al. Guidelines for the diagnosis and management of aplastic anemia [J]. Br J Haematol, 2009,147 : 43 -70.
  • 2Qiao Xiao-hong, Xie Xiao-tian, Jiang Sha-yi, et al. Experimental bone marrow failure in mice ameliorated by OCH via tippling the balance of released cytokines from Thl to Th2 [ J ]. Immunopharmacol Immunot- oxicol, 2012,34(3) : 491 -498.
  • 3傅晓燕,谢晓恬,蒋莎义,石苇,邵越霞.抗胸腺细胞球蛋白治疗儿童再生障碍性贫血的临床研究[J].中华儿科杂志,2011,49(3):226-230. 被引量:12
  • 4Xie Xiaotian, Shi Wei, Zhou Xiaoxun, et al. Comparison of rabbit antithymocyte globulin and Jurkat cell-reactive anti-t lymphocyte globulin as a first-line treatment for children with aplastic anemia [ J ]. Exp Hematol, 2014,42 : 431 - 438.
  • 5Simoni Y, Diana J, Ghazarian L, et al. Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality? [J]. Clini Exp Immunol, 2013,171(1) : 8-19.
  • 6张之南,沈悌.血液病诊断及治疗标准[M].3版.北京:科学技术出版社,2007:172-174.
  • 7Godfrey DI, Stankovic S, Baxter AG. Raising the NKT cell family[ J]. Nat Immunol, 2010,11: 197- 206.
  • 8Berzins SP, Smyth MJ, Baxter AG. Presumed guilty: natural killer T cell defects and human disease [ J ]. Nat Rev Immunol, 2011,11(2) : 131 -142.
  • 9Amasaki K, Horiguchi S, Kurosaki M, et al. Induction of NKT Cell-specific immune responses in cancer tissues after NKT cell-targeted adoptive immuno-therapy[ J]. Clin Immunol, 2011,138 : 255 - 265.
  • 10Richter J, Neparidze N, Zhang L, et al. Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma[ J ]. Blood, 2013,121 423 - 430.

二级参考文献27

  • 1谢晓恬,王耀平,石苇.联合免疫抑制治疗儿童重型和难治型再生障碍性贫血[J].中国当代儿科杂志,2004,6(6):492-496. 被引量:14
  • 2第四届全国再生障碍性贫血学术会议.再生障碍性贫血诊断标准[J].中华血液学杂志,1987,(8).
  • 3Seheinberg P, Colin W, Nunez O, et al. Treatment of severe aplastie anemia with a combination of horse antithymoeyte globulin and eyelosporine, with or without sirolimus:a prospective randomized study. Haematologiea ,2009 ,94 :348-354.
  • 4Myung H, Kyoung H, Hyo S, et al. Predictors of response to immuno-suppressive therapy with antithymocyte globulin and cyclosporine and prognosticfaetors for survival in patients with severe aplastie anemia. Eur J Haematol,2009,84 : 154-159.
  • 5Bacigalupo A, Hows J, Gluckman E, et al. Bone marrow transplantation (BMT)versus immunosuppression for the treatment of severe aplastic anemia (SAA) , a report of the EBMT SAA working party. Br J Haematol, 1988, 70: 177-182.
  • 6Jakob R, Andr~ T. lmmunosuppressive treatment for aplastic anemia: are we hitting the ceiling. Haematologica,2009,94:310- 312.
  • 7Seheinberg P, Colin OW, Nunez O, et al. Treatmenl of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study. Haematologica,2009,94:348-354.
  • 8Howard SC, Naidu PE, Hu X J, et al. Natural history of moderate aplastic anemia in children. Pediatr Blood Cancer,2004,43 : 545- 551.
  • 9Shayi J, Yaoping W, Wei S, et al. The benefit of ATG in immunosuppressive therapy of children with moderate aplastic anemia. Pediatr Hematol Oncol,2009 ,26 :313-320.
  • 10Fuhrer M, Baumann I, Faldum A, et al. Immunosuppressive therapy for aplastic anaemia in children: a more severe disease predicts better survival. Blood ,2005,106:2102-2104.

共引文献19

同被引文献30

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部